Medicine and Dentistry
Hepatitis B
100%
Human Immunodeficiency Virus
100%
Hepatitis B Virus
70%
Hepatitis A
50%
Vaccination Coverage
50%
Men Who Have Sex with Men
50%
Infection
50%
Cross Sectional Study
50%
Pervasive Developmental Disorder
50%
Abacavir
50%
Male Breast Cancer
50%
Bone Mass
50%
Genetic Screening
50%
Case-Control Study
50%
High Risk Population
37%
Prevalence
37%
Arm
37%
Lamivudine
31%
Hepatitis B Antibody
25%
Hepatitis B Antigen
25%
Biological Marker
18%
Kidney Function
18%
Bone Turnover
18%
Medicine
17%
Breast Discharge
16%
Odds Ratio
15%
Chronic Hepatitis B
12%
Cystatin C
12%
Osteocalcin
12%
Neutrophil Gelatinase Associated Lipocalin
12%
Osteoprotegerin
12%
Highly Active Antiretroviral Therapy
10%
Diseases
10%
Lamivudine/Zidovudine
6%
Urinary System
6%
Tenofovir/Emtricitabine
6%
Abacavir/Lamivudine
6%
Lumbar Spine
6%
Antiretroviral Therapy
6%
Hip
6%
Amino Terminal Sequence
6%
Creatinine Clearance
6%
Collagen Type 1
6%
Procollagen
6%
Alkaline Phosphatase
6%
Creatinine
6%
Telopeptide
6%
Acute Hepatitis A
5%
Sensitivity and Specificity
5%
Disease Severity
5%
Keyphrases
Valve Tissue
50%
Aortic Valve
50%
Endocarditis
50%
Bone Effects
50%
Immunization Strategy
50%
Immunization Coverage
50%
Immunization Risk
50%
Nucleic Acid Amplification Test
50%
Abacavir
50%
Venereal Disease
50%
Neisseria Gonorrhoeae
50%
Pre-travel Advice
50%
Hepatitis B Infection
50%
Pre-travel
33%
Non-immune
33%
Travel Vaccinations
33%
Soluble Vascular Adhesion Molecule
25%
Aptima
25%
Rapid Methods
25%
Highly Active Antiretroviral Therapy (HAART)
25%
Travel Insurance
25%
Nipple Discharge
16%
Invasive Ductal Carcinoma
16%
Pre-travel Counselling
16%
Subsolar
16%
Young Travelers
16%
Travel Risk
16%
Risk Knowledge
16%
Journey Destination
16%
Daily Infections
16%
HBV Virus
16%
Monogenic Etiology
12%
Medical Assistance
12%
Travel Health
12%
Travel Patterns
12%
HIV Diagnosis
12%
Travel Destination
12%
HIV Care
12%
HIV Status
12%
Patient Travel
12%
HIV Status Disclosure
12%
HIV Medicine
12%
National Surveillance Data
10%
Travel Habits
10%
Vaccination Guidelines
10%
Estimated Creatinine Clearance
6%
Bone Mass Increase
6%
Renal Function Parameters
6%
Pharmacology, Toxicology and Pharmaceutical Science
Abacavir
100%
Biological Marker
50%
HIV
50%
Tenofovir
50%
E-Selectin
30%
Cell Adhesion Molecule
30%
C Reactive Protein
20%
Interleukin 6
20%
Myeloperoxidase
20%
Intercellular Adhesion Molecule 1
20%
Abacavir Plus Lamivudine
20%
Neutrophil Gelatinase Associated Lipocalin
20%
Breast Discharge
16%
P-Selectin
10%
Endothelial Dysfunction
10%
Lamivudine Plus Zidovudine
10%
Dimer
10%
Inflammation
10%
Emtricitabine
10%
Cardiovascular Risk
10%
High Density Lipoprotein
10%
D Dimer
10%
High Density Lipoprotein Cholesterol
10%
